BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Meijer B, Mulder CJ, Peters GJ, van Bodegraven AA, de Boer NK. Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review. World J Gastroenterol 2016; 22(40): 9012-9021 [PMID: 27833392 DOI: 10.3748/wjg.v22.i40.9012]
URL: https://www.wjgnet.com/1007-9327/full/v22/i40/9012.htm
Number Citing Articles
1
Ahmed B. Bayoumy, Melek Simsek, Margien L. Seinen, Chris J.J. Mulder, Azhar Ansari, Godefridus J. Peters, Nanne K. De Boer. The continuous rediscovery and the benefit–risk ratio of thioguanine, a comprehensive reviewExpert Opinion on Drug Metabolism & Toxicology 2020; : 1 doi: 10.1080/17425255.2020.1719996
2
Vishal Sharma, Saurabh Kedia, Vineet Ahuja. Personalized medicine to implementation science: Thiopurines set for the leapJGH Open 2022; 6(10): 651 doi: 10.1002/jgh3.12829
3
Caleb D. Swaim, Varun Dwivedi, Yi-Chieh Perng, Xu Zhao, Larissa A. Canadeo, Houda H. Harastani, Tamarand L. Darling, Adrianus C.M. Boon, Deborah J. Lenschow, Viraj Kulkarni, Jon M. Huibregtse. 6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLproiScience 2021; 24(10): 103213 doi: 10.1016/j.isci.2021.103213
4
Edvin Brusač, Mario-Livio Jeličić, Daniela Amidžić Klarić, Biljana Nigović, Sabina Keser, Ana Mornar. Development of a HPLC-DAD stability-indicating method and compatibility study of azathioprine and folic acid as a prerequisite for a monolayer fixed-dose combinationAnalytical Methods 2021; 13(11): 1422 doi: 10.1039/D1AY00294E
5
E H J Savelkoul, M H J Maas, A R Bourgonje, F Crouwel, V B C Biemans, N den Broeder, M G V M Russel, T E H Römkens, N K de Boer, G Dijkstra, F Hoentjen. Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn’s DiseaseJournal of Crohn's and Colitis 2022; 16(9): 1372 doi: 10.1093/ecco-jcc/jjac044
6
Debbie S. Deben, Dennis R. Wong, Adriaan A. van Bodegraven. Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel diseaseExpert Opinion on Drug Metabolism & Toxicology 2021; 17(12): 1433 doi: 10.1080/17425255.2021.2029406
7
Sofia A. W. van Moorsel, Debbie S. Deben, Rob H. Creemers, Bjorn Winkens, Paul Bus, Marieke J. Pierik, Melek Simsek, Nanne K. H. de Boer, Adriaan A. van Bodegraven, Dennis R. Wong. Predictive Algorithm for Thiopurine-Induced Hepatotoxicity in Inflammatory Bowel Disease PatientsTherapeutic Drug Monitoring 2022; 44(6): 747 doi: 10.1097/FTD.0000000000001031
8
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatmentsWorld Journal of Gastroenterology 2017; 23(33): 6030-6048 doi: 10.3748/wjg.v23.i33.6030
9
Albert J. Czaja. Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitisAlimentary Pharmacology & Therapeutics 2020; 51(12): 1286 doi: 10.1111/apt.15743
10
Xu Teng, Yingying Qi, Jing Li, Jie Wu. Effect of Exclusive Enteral Nutrition on Th17 Cells in Juvenile Rats with Inflammatory Bowel DiseaseInflammation 2021; 44(1): 261 doi: 10.1007/s10753-020-01328-4
11
Ali Eqbal, Alicia Martin, James D. Doecke, Desmond Patrick. Low‐dose thioguanine guided by therapeutic drug monitoring is a safe and effective alternative in inflammatory bowel disease patients intolerant to conventional thiopurinesInternal Medicine Journal 2023; 53(4): 559 doi: 10.1111/imj.15639
12
Ioana Păunică. Diagnostic and treatment difficulties in Crohn’s diseaseJournal of Clinical and Investigative Surgery 2016; 1(2): 47 doi: 10.25083/2559.5555.12.713
13
Alexander T. Elford, Stephanie Dimovski, Britt Christensen. Tricks and traps of thioguanine: a case report of myelotoxicityInternal Medicine Journal 2023; 53(6): 1089 doi: 10.1111/imj.16113
14
Floris F. van den Brand, Carin M. J. van Nieuwkerk, Bart J. Verwer, Ynto S. de Boer, Nanne K. H. de Boer, Chris J. J. Mulder, Elisabeth Bloemena, Christine M. Bakker, Jan M. Vrolijk, Joost P. H. Drenth, Adriaan C. I. T. L. Tan, Frank ter Borg, Martijn J. ter Borg, Sven J. van den Hazel, Akin Inderson, Maarten E. Tushuizen, Gerd Bouma. Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the NetherlandsAlimentary Pharmacology & Therapeutics 2018; 48(7): 761 doi: 10.1111/apt.14939
15
Tomohiro Fukuda, Makoto Naganuma, Shinya Sugimoto, Kosaku Nanki, Shinta Mizuno, Makoto Mutaguchi, Yoshihiro Nakazato, Nagamu Inoue, Haruhiko Ogata, Yasushi Iwao, Takanori Kanai, Emiko Mizoguchi. The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registryPLOS ONE 2017; 12(11): e0187737 doi: 10.1371/journal.pone.0187737
16
Helena Gensmyr-Singer, Mårten Werner, Pontus Karling. The drug-survival of low-dose thioguanine in patients with inflammatory bowel disease: a retrospective observational studyTherapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241228064
17
Meiran Chu, Xinglan An, Daoyu Zhang, Qi Li, Xiangpeng Dai, Hao Yu, Ziyi Li. Combination of the 6-thioguanine and disulfiram/Cu synergistically inhibits proliferation of triple-negative breast cancer cells by enhancing DNA damage and disrupting DNA damage checkpointBiochimica et Biophysica Acta (BBA) - Molecular Cell Research 2022; 1869(2): 119169 doi: 10.1016/j.bbamcr.2021.119169
18
Graziella Guariso, Marco Gasparetto. Treating children with inflammatory bowel disease: Current and new perspectivesWorld Journal of Gastroenterology 2017; 23(30): 5469-5485 doi: 10.3748/wjg.v23.i30.5469
19
Heike E. F. Becker, Karlijn Demers, Luc J. J. Derijks, Daisy M. A. E. Jonkers, John Penders. Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel diseaseFrontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1107976
20
Jeroen P.A. Houwen, Antoine C.G. Egberts, Anthonius de Boer, Erik M. van Maarseveen, Roderick H.J. Houwen, Arief Lalmohamed. Influence of allopurinol on thiopurine associated toxicity: A retrospective population‐based cohort studyBritish Journal of Clinical Pharmacology 2021; 87(5): 2333 doi: 10.1111/bcp.14625
21
Carla J. Gargallo-Puyuelo, Viviana Laredo, Fernando Gomollón. Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.681907
22
Paula Sousa, Nurulamin M Noor. Revisiting Drug Development for Older Molecules in IBDInflammatory Bowel Diseases 2023; 29(6): 1012 doi: 10.1093/ibd/izac220
23
Abhinav Vasudevan, Danny Con, Daniel R. van Langenberg. Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' replyAlimentary Pharmacology & Therapeutics 2024; 59(8): 1011 doi: 10.1111/apt.17957
24
Nanne K H de Boer, Laurent Peyrin-Biroulet, Bindia Jharap, Jeremy D Sanderson, Berrie Meijer, Imke Atreya, Murray L Barclay, Jean-Frederic Colombel, Anthony Lopez, Laurent Beaugerie, Anthony M Marinaki, Adriaan A van Bodegraven, Markus F Neurath. Thiopurines in Inflammatory Bowel Disease: New Findings and PerspectivesJournal of Crohn's and Colitis 2018; 12(5): 610 doi: 10.1093/ecco-jcc/jjx181
25
Femke Crouwel, Ahmed B Bayoumy, Chris J J Mulder, Job H C Peters, Paul J Boekema, Luc J J Derijks, Sybrand Y de Boer, Paul C van de Meeberg, Ishfaq Ahmad, Hans J C Buiter, Nanne K de Boer. The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease PatientsInflammatory Bowel Diseases 2023;  doi: 10.1093/ibd/izad197
26
Melek Simsek, Berrie Meijer, Adriaan A. van Bodegraven, Nanne K.H. de Boer, Chris J.J. Mulder. Finding hidden treasures in old drugs: the challenges and importance of licensing genericsDrug Discovery Today 2018; 23(1): 17 doi: 10.1016/j.drudis.2017.08.008
27
Gerassimos J. Mantzaris. Thiopurines and Methotrexate Use in IBD Patients in a Biologic EraCurrent Treatment Options in Gastroenterology 2017; 15(1): 84 doi: 10.1007/s11938-017-0128-0
28
Hongyan Zeng, Li Li, Yaping Ding, Qi Zhuang. Simple and selective determination of 6-thioguanine by using polyethylenimine (PEI) functionalized carbon dotsTalanta 2018; 178: 879 doi: 10.1016/j.talanta.2017.09.087
29
Nanne K H de Boer, Melek Simsek, Berrie Meijer, Markus F Neurath, Ad van Bodegraven, Chris J J Mulder. Drug rediscovery in gastroenterology: from off-label to on-label use of thioguanine in inflammatory bowel diseaseGut 2023; 72(10): 1985 doi: 10.1136/gutjnl-2023-329679
30
Ashkan Rezazadeh Ardabili, Steven Jeuring, Zlatan Mujagic, Liekele Oostenbrug, Mariëlle Romberg‐Camps, Daisy Jonkers, Adriaan van Bodegraven, Marieke Pierik. Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics 2022; 56(6): 1030 doi: 10.1111/apt.17128
31
Anuraag Jena, Pardhu B Neelam, Harshavardhan Telaprolu, Uday Kiran Mangipudi, Usha Dutta, Shaji Sebastian, Vishal Sharma. Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regressionClinics and Research in Hepatology and Gastroenterology 2023; 47(7): 102155 doi: 10.1016/j.clinre.2023.102155
32
Femke Crouwel, Hans J C Buiter, Nanne K H de Boer. There is still a place for optimised thiopurine therapy in IBDGut 2021; 70(11): 2207 doi: 10.1136/gutjnl-2020-323481
33
Femke Crouwel, Hans J C Buiter, Nanne K de Boer. The Thiopurine Tale: An Unexpected JourneyJournal of Crohn's and Colitis 2022; 16(7): 1177 doi: 10.1093/ecco-jcc/jjac004
34
Tingting Qiu, Huibo Li, Tong Sun, Peng Men, Xiangli Cui, Cuiwen Liu, Suodi Zhai. Thalidomide as a treatment for inflammatory bowel disease in children and adolescents: A systematic reviewJournal of Clinical Pharmacy and Therapeutics 2020; 45(5): 1134 doi: 10.1111/jcpt.13196
35
Ramya Movva, Alison Haywood, Sohil A Khan, Timothy HJ Florin, Iulia Oancea. Critical assessment of thioguanine treatment for inflammatory bowel diseases: Is it time to rehabilitate this treatment?Journal of Digestive Diseases 2017; 18(9): 529 doi: 10.1111/1751-2980.12536
36
Melek Simsek, Femke Schepers, Sigal Kaplan, Dirk van Asseldonk, Petra van Boeckel, Paul Boekema, Gerard Dijkstra, Herma Fidder, Ingrid Gisbertz, Frank Hoentjen, Bindia Jharap, Frank Kubben, Marleen de Leest, Maarten Meijssen, Ana Petrak, Else van de Poel, Maurice Russel, Adriaan A van Bodegraven, Chris J J Mulder, Nanne de Boer. Thioguanine is Effective as Maintenance Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Registry StudyJournal of Crohn's and Colitis 2023; 17(6): 933 doi: 10.1093/ecco-jcc/jjad013
37
Yuichiro Kojima, Yosuke Hirotsu, Wataru Omata, Makoto Sugimori, Shinya Takaoka, Hiroshi Ashizawa, Keiko Nakagomi, Dai Yoshimura, Kenji Hosoda, Yoji Suzuki, Hitoshi Mochizuki, Masao Omata. Influence of <i>NUDT15</i> variants on hematological pictures of patients with inflammatory bowel disease treated with thiopurinesWorld Journal of Gastroenterology 2018; 24(4): 511-518 doi: 10.3748/wjg.v24.i4.511
38
Chunhe Yu, Xiaohua Jiang, Dongmiao Qin, Guichun Mo, Xiangfei Zheng, Biyang Deng. Facile Syntheses of S,N-Codoped Carbon Quantum Dots and Their Applications to a Novel Off–On Nanoprobe for Detection of 6-Thioguanine and Its BioimagingACS Sustainable Chemistry & Engineering 2019; 7(19): 16112 doi: 10.1021/acssuschemeng.9b02886
39
Sjoerd de Hoogd, Dennis R. Wong, Durk R. de Vries, Ankie M. Harmsze. Severe pancytopenia and aspergillosis caused by thioguanine in a thiopurine S-methyltransferase deficient patient: a case reportEuropean Journal of Gastroenterology & Hepatology 2019; 31(12): 1592 doi: 10.1097/MEG.0000000000001504
40
Tim Raine, Bram Verstockt, Uri Kopylov, Konstantinos Karmiris, Rimma Goldberg, Raja Atreya, Johan Burisch, John Burke, Pierre Ellul, Charlotte Hedin, Stefan D Holubar, Konstantinos Katsanos, Triana Lobaton, Carsten Schmidt, Garret Cullen. ECCO Topical Review: Refractory Inflammatory Bowel DiseaseJournal of Crohn's and Colitis 2021; 15(10): 1605 doi: 10.1093/ecco-jcc/jjab112
41
Wenjing Chen, Jun Fan, Xianxue Wu, Dongbao Hu, Yunying Wu, Zhongmin Feng, Meiyun Yan, Xizhu Gao, Jianxin Xie. Facile synthesis of nitrogen-doped carbon dots from pork liver and its sensing of 6-thioguanine based on the inner filter effectNew Journal of Chemistry 2021; 45(11): 5114 doi: 10.1039/D0NJ05483F
42
Nanne K.H. de Boer, Vineet Ahuja, Sven Almer, Azhar Ansari, Rupa Banerjee, Murray L. Barclay, Jake Begun, Adriaan A. van Bodegraven, Jean-Frederic Colombel, David P. Epstein, Timothy H.J. Florin, Richard B. Gearry, Javier P. Gisbert, Rupert W. Leong, Chris J.J. Mulder, Markus F. Neurath, Graham L. Radford-Smith, Margien L. Seinen, Melek Simsek, Miles P. Sparrow. Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old OnesGastroenterology 2019; 156(1): 11 doi: 10.1053/j.gastro.2018.11.039
43
Diego Vergani, Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani. A reasoned approach to the treatment of autoimmune hepatitisDigestive and Liver Disease 2021; 53(11): 1381 doi: 10.1016/j.dld.2021.05.033
44
Burton I. Korelitz, David B. Sachar, Judy Schneider. Full Potential of 6-Mercaptopurine in IBD May Remain UntappedAmerican Journal of Gastroenterology 2020; 115(12): 2109 doi: 10.14309/ajg.0000000000000769
45
Ahmed B. Bayoumy, Elsa L. S. A. van Liere, Melek Simsek, Ben Warner, Aathavan Loganayagam, Jeremy D. Sanderson, Simon Anderson, Jonathan Nolan, Nanne K. de Boer, Chris J. J. Mulder, Azhar Ansari. Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United KingdomBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01441-6
46
Zhaojie Li, Chuantao Peng, Yaru Sun, Tao Zhang, Cuijiao Feng, Weiqin Zhang, Tian Huang, Guoqiang Yao, Heping Zhang, Qiuwen He, Francesca Turroni. Both viable Bifidobacterium longum subsp. infantis B8762 and heat-killed cells alleviate the intestinal inflammation of DSS-induced IBD rats Microbiology Spectrum 2024;  doi: 10.1128/spectrum.03509-23
47
Vince B. C. Biemans, Edo Savelkoul, Ruben Y. Gabriëls, Melek Simsek, Gerard Dijkstra, Marieke J. Pierik, Rachel L. West, Nanne K.H. de Boer, Frank Hoentjen. A comparative analysis of tioguanine versus low‐dose thiopurines combined with allopurinol in inflammatory bowel disease patientsAlimentary Pharmacology & Therapeutics 2020; 51(11): 1076 doi: 10.1111/apt.15730
48
Femke Crouwel, Melek Simsek, Amarylle S van Doorn, Chris J J Mulder, Hans J C Buiter, Murray L Barclay, Timothy H Florin, Nanne K de Boer. Rectally Administrated Thioguanine for Distal Ulcerative Colitis: A Multicenter Case SeriesInflammatory Bowel Diseases 2023; 29(6): 1000 doi: 10.1093/ibd/izac195
49
Melek Simsek, Debbie S. Deben, Carmen S. Horjus, Melanie V. Bénard, Birgit I. Lissenberg‐Witte, Hans J. C. Buiter, Matthijs van Luin, Margien L. Seinen, Chris J. J. Mulder, Dennis R. Wong, Nanne K. H. de Boer, Adriaan A. van Bodegraven. Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapiesAlimentary Pharmacology & Therapeutics 2019; 50(1): 54 doi: 10.1111/apt.15280
50
Kirtesh Pratap Khare, Rachana Kathal, Neelima Shukla, Reena Srivastava, Anurag Srivastava. Suitability of ZnO Nanocomposite of Copolymer (PPy-PNVK-ZnO) (PPy = Polypyrrole; PNVK = Poly 9-vinyl carbazole) for the Detection of 6-Thioguanine: A DFT AnalysisAsian Journal of Chemistry 2023; 35(2): 422 doi: 10.14233/ajchem.2023.26881
51
Mohammad Shir Ali, Robyn Laube, Sriharan Selvaratnam, Rupert W. Leong. Tioguanine as an alternative immunomodulator in inflammatory bowel diseasesInternal Medicine Journal 2020; 50(11): 1434 doi: 10.1111/imj.15057
52
Nicola Pugliese, Lucia Giuli, Elisabetta Mastrorocco, Francesco Santopaolo, Giacomo Marcozzi, Cristina Bezzio, Arianna Dal Buono, Roberto Gabbiadini, Antonio Gasbarrini, Francesca Romana Ponziani, Alessandro Armuzzi, Alessio Aghemo. Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease – A comprehensive narrative reviewDigestive and Liver Disease 2024; 56(6): 964 doi: 10.1016/j.dld.2023.11.021